Common Neonatal Syndromes
The most common neonatal syndromes include respiratory distress syndrome (RDS), transient tachypnea of the newborn (TTN), neonatal sepsis, bronchopulmonary dysplasia/chronic lung disease of infancy (BPD/CLDI), and genetic syndromes such as trisomy 13 and trisomy 18.
Respiratory Syndromes
Respiratory Distress Syndrome (RDS)
RDS predominantly affects preterm infants, particularly those with birth weights <1,500g and especially <1,000g 1. The syndrome results from surfactant deficiency and is characterized by:
- Poorly aerated lungs with absence of A-lines on ultrasound
- Small "sub-pleural" consolidations
- Diffuse white lung pattern (confluent B-lines) 2
Surfactant replacement therapy is the definitive treatment, reducing mortality (RR: 0.56), bronchopulmonary dysplasia (RR: 0.57), and complications like pneumothorax 1. Prophylactic surfactant administration within 10-30 minutes of birth for infants ≤30 weeks gestation reduces death (RR: 0.61; NNT: 22) and pneumothorax (RR: 0.62; NNT: 47) compared to rescue therapy 1.
Transient Tachypnea of the Newborn (TTN)
TTN presents with an interstitial pattern that alternates with areas of near-normal lung showing A-lines on ultrasound, distinguishing it from RDS 2. This self-limited condition typically resolves within days and requires supportive care only.
Bronchopulmonary Dysplasia/Chronic Lung Disease of Infancy (CLDI)
CLDI represents the final common pathway of heterogeneous pulmonary disorders starting in the neonatal period 3. It most commonly evolves from:
- RDS in premature infants requiring mechanical ventilation and oxygen
- Pneumonia/sepsis
- Meconium aspiration
- Any acute lung injury requiring positive-pressure ventilation and high oxygen concentrations 3
This is truly a multisystem disorder with far-reaching consequences extending into childhood, requiring interdisciplinary management 3.
Infectious Syndromes
Neonatal Sepsis
Neonatal sepsis accounts for approximately 22% of global neonatal deaths 4. The syndrome is categorized as:
Early-Onset Sepsis (EOS): Within 72 hours to 7 days of birth
- Traditionally caused by group B streptococcus and enteric Gram-negative bacteria
- Acquired peripartum from maternal genital tract
Late-Onset Sepsis (LOS): After the early neonatal period
- Hospital-acquired pathogens
- Risk factors: very low birth weight, early gestational age 4
Critical caveat: In low- and lower-middle-income countries, Gram-negative bacteria account for 60% of neonatal sepsis, with high resistance rates against WHO-recommended empirical antibiotics (gentamicin with ampicillin or benzylpenicillin) 4. This represents a major treatment challenge requiring region-specific antibiotic protocols.
In neonates, sepsis presents with nonspecific signs:
- Feeding difficulties
- Respiratory distress
- Tachycardia and hypotension
- Neurological symptoms (seizures, apnea, hemiparesis)
- New or changing heart murmur 5
Genetic Syndromes
Trisomy 13 and Trisomy 18
These chromosomal abnormalities are recognizable in the neonatal period and require specific management approaches 6. Prenatal consultation with neonatal clinicians should occur at the earliest opportunity to provide accurate, nonbiased information through shared decision-making 6.
Management options include:
- Comfort-focused care with perinatal hospice/palliative care involvement
- "Trial of therapy" approach to treat reversible causes of respiratory distress (e.g., transient tachypnea of the newborn)
- Time-limited interventions to allow family bonding and completion of postnatal evaluation 6
Important distinction: These are not universally lethal disorders, making it unethical to present only comfort care options 6.
Other Genetic Syndromes
Multiple genetic syndromes present in the neonatal period with characteristic phenotypes 7, 8:
- Syndromes with characteristic facies and limb malformations
- Overgrowth syndromes
- Syndromes with neonatal growth deficit
- Neuro-ectodermic syndromes
- Craniofacial syndromes 9
Phenotype recognition is crucial as it directs specific diagnostic studies, prevents unnecessary expensive procedures, and enables appropriate family counseling 8.
Neonatal Epileptic Syndromes
These include self-limited neonatal syndromes and early infantile epileptic and developmental encephalopathies (EIDEE) 10, 11:
Self-limited syndromes: Seizures resolve within first months with normal development, though some may have seizure recurrence or learning disorders
EIDEE: Refractory seizures affecting neurodevelopment, including:
- Early myoclonic encephalopathy
- Ohtahara syndrome
- Pyridoxine dependency
- Glucose transporter type 1 syndrome 11
Critical diagnostic point: Many abnormal intermittent behaviors in neonates are not accompanied by ictal EEG patterns, and <50% of neonatal seizures show abnormal clinical behavior, particularly after anticonvulsant treatment 11.